DPP HIV 1/2 Assay regulatory update

Chembio said it now expects a delay on a CLIA waiver application under review by FDA for its DPP HIV 1/2 Assay as an aid in diagnosing HIV/AIDS infection in patients >=2 years. The company, which prev...